Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

SELL
$1.63 - $3.52 $9,209 - $19,888
-5,650 Reduced 22.6%
19,350 $32,000
Q3 2022

Oct 27, 2022

BUY
$0.73 - $3.74 $2,518 - $12,903
3,450 Added 16.01%
25,000 $78,000
Q2 2022

Aug 08, 2022

BUY
$2.2 - $4.2 $18,150 - $34,650
8,250 Added 62.03%
21,550 $62,000
Q1 2022

Apr 28, 2022

BUY
$2.83 - $8.69 $37,639 - $115,577
13,300 New
13,300 $54,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $13.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.